Acquisition, Sale of Hospira Infusion Systems Net Assets, Licensing Arrangement and Collaborative Arrangements - Licensing Arrangement (Details) - Shire [Member] - Licensing Arrangement [Member] - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Apr. 01, 2018	Dec. 31, 2016
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Maximum amount of possible development and sales-based milestone payments and potential future royalty payments		$ 460
Other (Income)/Deductions, Net [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payments received	$ 75	$ 90